Relec Electronics announces range of TFT displays from Futurelabs

TFT displays manufactured by Futurelabs and now available from Relec Electronics  range in size from 3.5” to 17” and to meet user demands are available with optional PCAP (projective capacitive) touchscreens. The displays offer extended operating temperatures ranging from -40°Celsius to +85°Celsius, making them suitable for use in harsh environments. They also have IPS (in-plane switching) technology to provide users with wide viewing angles in a range of lighting conditions in both indoor and outdoor applications.

The Futurelabs IPS TFT liquid crystal display (LCD) modules are available in 3.5”, 5.0”, 7.0”, 10”, 10.4”, 12.1”, 15.6” and 17” versions. There is also a 12.3” letterbox LVDS TFT LCD. All Futurelabs displays can be specified with Rocktouch Rugged line PCAP touch panels, claimed to offer best in class performance, noise and water resistance. They are also available with a range of input options: for example, glove touch, operation with water and firmware tuning. Resolutions range from 640 x 480 RGB pixels to 1280 x 800 RGB pixels, and brightness levels are from 400 cd/M2 to 1000 cd/M2, depending on the model. Relec says that the displays can be customised with touchscreens, mounting frames, cover lenses, optical bonding, surface treatments and enhancement films. The TFT LCDs are stated to be well suited for use indoors or outdoors.

Futurelabs also offers a wide range of suitable replacement TFT for products from Mitsubishi, either standard parts or with AIR or Spectrum Bonding – their in-house optical bonding technique.

Relec Electronics says it is Futurelabs’ premier UK design centre and that its  partnership with Futurelabs offers unparalleled product and customer service for standard displays.

Relec confirms that it offers a range of options to support engineers in finding the right display for a specific project and application as well as a range of options, including optical bonding, enhancement films, DSA bonding and anti-bacterial treatments.